Clearpoint Neuro Inc (CLPT) 13F Investor Activity Report (Q2 2026)

CLPT ranks #3951 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

CLPT is a top-conviction position for Lane Generational LLC — at 7.0% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CLPT belongs to BlackRock, Inc., but the position matters far more to Lane Generational LLC, who has 7.0% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

CLPT is down 5.9% today, but institutions show net buying of $29.1M this quarter — a divergence between today's price move and the underlying institutional flow.

CLPT reported a net loss of $34.6M over the trailing twelve months.

• Not yet profitable — net loss of $34.6M over the trailing twelve months
• Revenue grew 25.9% year over year
• Net income declined year over year, from -$22.2M to -$34.6M
• Operating cash flow was negative, using $23.9M in cash
• Current ratio of 5.91x — enough short-term assets to cover short-term liabilities
• Liabilities run 2.49x equity — a highly leveraged balance sheet worth noting